Gabelli Funds’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-295,915
| Closed | -$54.4M | – | 1501 |
|
|
2021
Q2 | $54.4M | Buy |
295,915
+43,500
| +17% | +$7.99M | 0.35% | 72 |
|
|
2021
Q1 | $38.6M | Buy |
252,415
+139,714
| +124% | +$21.4M | 0.26% | 106 |
|
|
2020
Q4 | $17.6M | Buy |
112,701
+71,701
| +175% | +$11.2M | 0.13% | 209 |
|
|
2020
Q3 | $4.69M | Hold |
41,000
| – | – | 0.04% | 455 |
|
|
2020
Q2 | $4.6M | Hold |
41,000
| – | – | 0.04% | 452 |
|
|
2020
Q1 | $3.68M | Sell |
41,000
-10,000
| -20% | -$898K | 0.03% | 482 |
|
|
2019
Q4 | $5.52M | Sell |
51,000
-5,000
| -9% | -$541K | 0.04% | 479 |
|
|
2019
Q3 | $5.49M | Buy |
56,000
+5,000
| +10% | +$490K | 0.04% | 485 |
|
|
2019
Q2 | $6.68M | Buy |
51,000
+2,500
| +5% | +$327K | 0.04% | 443 |
|
|
2019
Q1 | $6.56M | Sell |
48,500
-3,900
| -7% | -$527K | 0.04% | 452 |
|
|
2018
Q4 | $5.1M | Buy |
52,400
+17,400
| +50% | +$1.69M | 0.04% | 499 |
|
|
2018
Q3 | $4.87M | Sell |
35,000
-1,000
| -3% | -$139K | 0.03% | 578 |
|
|
2018
Q2 | $4.47M | Sell |
36,000
-11,500
| -24% | -$1.43M | 0.03% | 597 |
|
|
2018
Q1 | $5.29M | Buy |
47,500
+13,300
| +39% | +$1.48M | 0.03% | 542 |
|
|
2017
Q4 | $4.09M | Buy |
34,200
+23,000
| +205% | +$2.75M | 0.02% | 616 |
|
|
2017
Q3 | $1.57M | Sell |
11,200
-9,800
| -47% | -$1.37M | 0.01% | 829 |
|
|
2017
Q2 | $2.56M | Buy |
+21,000
| New | +$2.56M | 0.02% | 715 |
|
|
2015
Q3 | – | Sell |
-1,316
| Closed | -$238K | – | 1109 |
|
|
2015
Q2 | $238K | Buy |
+1,316
| New | +$238K | ﹤0.01% | 1036 |
|